Study may result in more targeted drugs for GIST

According to Oregon Health and Science University Knight Cancer Institute researchers, there is strong evidence that patients can have varying clinical responses to medications depending on the specific makeup of their cancer. The study, which focused on, gastrointestinal stromal tumours, also called GIST, found that the genetic variations in their disease appear to determine which medications will be most effective...

Read the whole article on

More from